Literature DB >> 11796562

Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.

William J McKenna1, Elijah R Behr.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 11796562      PMCID: PMC1767009          DOI: 10.1136/heart.87.2.169

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  23 in total

1.  Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.

Authors:  P M Elliott; J R Gimeno Blanes; N G Mahon; J D Poloniecki; W J McKenna
Journal:  Lancet       Date:  2001-02-10       Impact factor: 79.321

2.  Hypertrophic cardiomyopathy and sudden death.

Authors:  P Nicod; R Polikar; K L Peterson
Journal:  N Engl J Med       Date:  1988-05-12       Impact factor: 91.245

3.  Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy.

Authors:  W J McKenna; R C Franklin; P Nihoyannopoulos; K C Robinson; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1988-01       Impact factor: 24.094

4.  Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy.

Authors:  P Spirito; B J Maron; R O Bonow; S E Epstein
Journal:  Am J Cardiol       Date:  1987-07-01       Impact factor: 2.778

5.  Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.

Authors:  W J McKenna; C M Oakley; D M Krikler; J F Goodwin
Journal:  Br Heart J       Date:  1985-04

6.  Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration.

Authors:  C Pollick
Journal:  Am J Cardiol       Date:  1988-12-01       Impact factor: 2.778

7.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

Authors:  P M Elliott; J Poloniecki; S Dickie; S Sharma; L Monserrat; A Varnava; N G Mahon; W J McKenna
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

8.  Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest.

Authors:  F Cecchi; B J Maron; S E Epstein
Journal:  J Am Coll Cardiol       Date:  1989-05       Impact factor: 24.094

9.  Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.

Authors:  W McKenna; J Deanfield; A Faruqui; D England; C Oakley; J Goodwin
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

10.  Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.

Authors:  B J Maron; D D Savage; J K Wolfson; S E Epstein
Journal:  Am J Cardiol       Date:  1981-08       Impact factor: 2.778

View more
  37 in total

Review 1.  Sudden death in children and adolescents.

Authors:  Christopher Wren
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 2.  Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy.

Authors:  Michael P Frenneaux
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 3.  Hypertrophic cardiomyopathy.

Authors:  Carolyn Y Ho
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

4.  Clinical spectrum in a family with tropomyosin-mediated hypertrophic cardiomyopathy and sudden death in childhood.

Authors:  Majd Makhoul; Michael J Ackerman; Dianne L Atkins; Ian H Law
Journal:  Pediatr Cardiol       Date:  2010-11-19       Impact factor: 1.655

5.  Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  P P Dimitrow; J S Dubiel
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

Review 6.  Exercise: friend or foe?

Authors:  Frida J Dangardt; William J McKenna; Thomas F Lüscher; John E Deanfield
Journal:  Nat Rev Cardiol       Date:  2013-06-25       Impact factor: 32.419

7.  Pacing for hypertrophic obstructive cardiomyopathy does it work?

Authors:  Q Zaidi; H Zaky; O Aljassim
Journal:  J Saudi Heart Assoc       Date:  2009-08-05

Review 8.  Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes.

Authors:  Jil C Tardiff
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

9.  The missing spade: apical hypertrophic cardiomyopathy investigation.

Authors:  F Alpendurada; S K Prasad
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-02       Impact factor: 2.357

10.  Focal energy deprivation underlies arrhythmia susceptibility in mice with calcium-sensitized myofilaments.

Authors:  Sabine Huke; Raghav Venkataraman; Michela Faggioni; Sirish Bennuri; Hyun S Hwang; Franz Baudenbacher; Björn C Knollmann
Journal:  Circ Res       Date:  2013-03-26       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.